Abiraterone (CED0002576)

Record Information
Version1.0
Creation Date2026-04-04 18:11:13 UTC
Update Date2026-05-14 18:16:25 UTC
Accession NumberCHEM077355
Identification
Common NameAbiraterone
ClassSmall Molecule
Description
Abiraterone belongs to the androstane steroids, a subclass of steroids and steroid derivatives within the organic compounds. This compound has the formula C24H31N1O1 and an average molecular weight of 349.52 g/mol. It is found in healthcare, pharmaceuticals, and veterinary products, specifically as an antineoplastic agent and a hormone antagonist and related agent. The recorded route of exposure for this compound is oral. At the molecular level, abiraterone acts as an inhibitor of the protein target Steroid 17-alpha-hydroxylase/17,20 lyase (CYP17A1). Use of the compound is associated with several health effects, including edema (PMC9869701), hypokalemia (PMC9869701), and cognitive impairment (PMC9869701). Additionally, it is linked to hypertension (PMC9869701) and an increase in both hypertension (PMC9869701) and heart failure (PMC9869701).
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC24H31N1O1
Average Molecular Mass349.518 g/mol
Monoisotopic Mass349.241 g/mol
CAS Registry Number154229-19-3
IUPAC NameNot Available
Traditional NameNot Available
SMILES[H][C@@]12CC=C(C3=CN=CC=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C
InChI IdentifierInChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3
InChI KeyGZOSMCIZMLWJML-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-00ec-0339000000-3e80164149e9337fceb9Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0ue9-0009000000-f4738f825cc7fe2c7996Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0lz9-0398000000-f6f3cd67aaa6879960b9Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0uyi-1931000000-2522432767a2710b7745Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0002-0009000000-6c1484950308d6d26c80Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0002-0009000000-2df26d5475b8776b16c7Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0002-0239000000-37b99e79ba035060af9bNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
715.0Log mg/kg[400:1300]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
hypertensionassociated_withincreasePMC9869701 , PMC9869701
hypertensionassociated_withNot AvailablePMC9869701
heart failureassociated_withincreasePMC9869701
edemaassociated_withNot AvailablePMC9869701
cognitive impairmentassociated_withNot AvailablePMC9869701
hypokalemiaassociated_withNot AvailablePMC9869701
Exposure Sources
Source IDSourceSectorReference
358Antineoplastic agentsHealthcare, pharmaceuticals & veterinary productsNot Available
360Hormone antagonists and related agentsHealthcare, pharmaceuticals & veterinary productsNot Available
Pathways
1 pathway
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Steroid 21-hydroxylase structureClick to view 3D structureSteroid 21-hydroxylaseP08686HumansPredicted (SEA)0.0778492
Steroid 17-alpha-hydroxylase/17,20 lyase structureClick to view 3D structureSteroid 17-alpha-hydroxylase/17,20 lyaseP05093HumansPredicted (SEA)0.0778492
Click to view 3D structureSteroid 17-alpha-hydroxylase/17,20 lyaseQ2XVA1Macaca fascicularisPredicted (SEA)0.0778492
Click to view 3D structureSteroid 17-alpha-hydroxylase/17,20 lyaseP11715Rattus norvegicusPredicted (SEA)0.311397
Cytochrome P450 11B1, mitochondrial structureClick to view 3D structureCytochrome P450 11B1, mitochondrialP15538HumansPredicted (SEA)0.700643
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)36.7448
Aromatase structureClick to view 3D structureAromataseP11511HumansPredicted (SEA)6.22794
NPC1-like intracellular cholesterol transporter 1 structureClick to view 3D structureNPC1-like intracellular cholesterol transporter 1Q9UHC9HumansPredicted (SEA)1.63483
Androgen receptor structureClick to view 3D structureAndrogen receptorP10275HumansPredicted (SEA)12.923
Oxysterol-binding protein 1 structureClick to view 3D structureOxysterol-binding protein 1P22059HumansPredicted (SEA)1.55698
Click to view 3D structureOxysterol-binding protein 2Q969R2HumansPredicted (SEA)1.55698
Oxysterols receptor LXR-alpha structureClick to view 3D structureOxysterols receptor LXR-alphaQ13133HumansPredicted (SEA)16.8933
Sex hormone-binding globulin structureClick to view 3D structureSex hormone-binding globulinP04278HumansPredicted (SEA)5.91654
Corticosteroid-binding globulin structureClick to view 3D structureCorticosteroid-binding globulinP08185HumansPredicted (SEA)5.3716
Cytochrome P450 11B2, mitochondrial structureClick to view 3D structureCytochrome P450 11B2, mitochondrialP19099HumansPredicted (SEA)5.13805
Nuclear receptor ROR-gamma structureClick to view 3D structureNuclear receptor ROR-gammaP51449HumansPredicted (SEA)25.3788
Click to view 3D structureGlucose-6-phosphate 1-dehydrogenaseQ9GRG7Trypanosoma bruceiPredicted (SEA)2.64687
Estrogen receptor structureClick to view 3D structureEstrogen receptorP03372HumansPredicted (SEA)39.7031
Estrogen receptor beta structureClick to view 3D structureEstrogen receptor betaQ92731HumansPredicted (SEA)30.439
Click to view 3D structureAndrogen receptorP15207Rattus norvegicusPredicted (SEA)21.3307
Click to view 3D structureEphrin type-A receptor 7Q61772Mus musculusPredicted (SEA)3.03612
Click to view 3D structureEphrin type-B receptor 3P54754Mus musculusPredicted (SEA)3.03612
Click to view 3D structureEphrin type-B receptor 1P09759Rattus norvegicusPredicted (SEA)3.03612
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)311.708
Click to view 3D structureOxysterols receptor LXR-betaQ62755Rattus norvegicusPredicted (SEA)1.94623
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available